Move your body
Clinical outcomes The primary end points were the participant incidence of TEAEs, changes in laboratory safety tests, vital signs and 12-lead electrocardiograms
These effects typically decrease as your body adjusts, and your PlexusDx prescriber can adjust your dose pace if side effects become bothersome
The Founding Paper: Coskun et al., 2022 Coskun, Urva, Roell, and colleagues reported the discovery and preclinical characterization of LY3437943 in Cell Metabolism in 2022 [1]
It may be prescribed alone or with other diabetes medications such as metformin, sulfonylureas, or insulin
Description Additional information Description GLP-3R (LY-3437943) Peptide **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form